<DOC>
	<DOCNO>NCT01099397</DOCNO>
	<brief_summary>The purpose study determine , subset patient treat beta-blocker diuretic , prediabetes detectable great extent 2-hour oral glucose tolerance test ( OGTT ) compare fast glucose measurement .</brief_summary>
	<brief_title>Antihypertensive Medication Exposure Risk Impaired Glucose Tolerance : A PEAR Sub-Study</brief_title>
	<detailed_description>Beta-blockers diuretic well-established role treat hypertension frequently use first-line . However , increasingly evident medication harmful metabolic effect . The Pharmacogenomic Evaluation Antihypertensive Responses ( PEAR - NCT00246519 ) study great 700 participant , randomize , parallel assignment trial , aim determine genetic factor influence response beta-blocker ( atenolol ) diuretic ( hydrochlorothiazide [ HCTZ ] ) . The PEAR trial design include evaluation baseline , monotherapy either medication , combination therapy medication . This pilot , PEAR sub-study aim characterize ability two diagnostics test ( fast glucose versus glucose 2-hours OGTT ) detect prediabetes development prior blood pressure medication use , monotherapy ( atenolol HCTZ ) combination therapy ( atenolol HCTZ ) .</detailed_description>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>participation PEAR : average seat home DBP &gt; 85 mmHg home SBP &lt; 180 mmHg . subject must also average seated ( &gt; 5 minute ) clinic DBP 90 mmHg 110 mmHg SBP &lt; 180 mmHg . secondary form HTN , patient currently treat three antihypertensive drug , isolate systolic HTN , diseases require treatment BP lowering medication , heart rate &lt; 55 beats/min , know cardiovascular disease ( include history angina pectoris , heart failure , presence cardiac pacemaker , history myocardial infarction revascularization procedure , cerebrovascular disease , include stroke TIA ) , diabetes mellitus ( Type 1 2 ) , renal insufficiency ( serum creatinine &gt; 1.5 men 1.4 woman ) , primary renal disease , pregnancy lactation , liver enzymes &gt; 2.5 upper limit normal , current treatment NSAIDS , COX2inhibitors , oral contraceptive estrogen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Glucose</keyword>
	<keyword>Glucose Tolerance Test</keyword>
	<keyword>Insulin Resistance</keyword>
	<keyword>Metabolic adverse effect</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Beta-blocker</keyword>
	<keyword>Atenolol</keyword>
	<keyword>Diuretic</keyword>
	<keyword>Hydrochlorothiazide</keyword>
	<keyword>Blood pressure</keyword>
</DOC>